Skip to main content
Erschienen in: Malaria Journal 1/2012

Open Access 01.10.2012 | Oral presentation

Malaria surveillance systems: from control to elimination

verfasst von: Richard E Cibulskis

Erschienen in: Malaria Journal | Sonderheft 1/2012

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
The capacity of malaria surveillance systems to provide accurate information on the distribution of and trends in malaria varies widely across the globe. It is influenced by (i) the extent to which patients seek treatment, (ii) whether patients use public sector health facilities, (iii) the proportion of patients that receive a diagnostic test, and (iv) the completeness of recording and reporting systems. When these factors are taken into account, it is estimated that malaria surveillance systems detect less than 10% of all cases globally, though the proportions are higher in the Europe (> 90%) and the Americas (50%). The characteristics of surveillance systems vary by geographical region. South-East Asia has the lowest percentage of malaria patients that seek treatment in public health facilities. Confirmatory diagnostic tests (blood slides or RDTs) are used infrequently in Africa, as compared with other regions. Reporting is most complete in the European region.
In April 2012 WHO released operational manuals for malaria surveillance to guide programmes both in the control phase and those in the elimination phase. In the control phase the objective of malaria programmes is to reduce the incidence of and mortality from malaria as rapidly and economically as possible. Many countries with high levels of malaria transmission are low- or lower middle-income countries, which have low expenditures per person on health care services. This results in weak health systems that are not easily accessed by the population, lower staff to patient ratios, frequent interruptions of medical supplies and limited use of parasitological diagnosis. Such settings pose particular challenges to the development of surveillance systems. Health systems in low-transmission settings are usually stronger than in high-transmission settings, and there may be widespread availability of parasitological diagnosis and appropriate treatment. Malaria may, however, be concentrated in marginalized populations, such as those living in remote border areas, migrant workers and tribal populations, and innovative ways may have to be found to reach these groups.
In the elimination phase cases occur sporadically or in distinct foci and imported cases may comprise a significant proportion of all cases. The aim of malaria programmes is to stop local transmission of malaria, and surveillance is a principal strategy for achieving this. All malaria infections are important and need to be detected, as they may lead to onward transmission (i.e., all persons with parasitaemia are considered a ‘malaria case’, regardless of the presence or absence of clinical symptoms). In practice, this is accomplished in two stages (i) by identifying all areas or foci with local transmission of malaria using reports of malaria cases from public and private sector health facilities. Each malaria case is then investigated to determine whether it was locally acquired or imported and, if so, from where. (ii) If a focus of local transmission is detected, the characteristics of transmission are determined and control and surveillance activities are then intensified in the focus.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
download
DOWNLOAD
print
DRUCKEN
Metadaten
Titel
Malaria surveillance systems: from control to elimination
verfasst von
Richard E Cibulskis
Publikationsdatum
01.10.2012
Verlag
BioMed Central
Erschienen in
Malaria Journal / Ausgabe Sonderheft 1/2012
Elektronische ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-11-S1-O1

Weitere Artikel der Sonderheft 1/2012

Malaria Journal 1/2012 Zur Ausgabe

Poster presentation

Abstract withdrawn

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.